Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical evaluation of 4-demethoxydaunorubicin in patients with advanced malignant lymphoma.

× No keyword cloud information.

6 in total

Review 1. Idarubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer.

Authors: L M Hollingshead; D Faulds
Journal: Drugs Date: 1991-10 Impact factor: 9.546

2. Phase II trial of idarubicin in patients with advanced lymphoma.

Authors: H Gillies; R Liang; H Rogers; P Harper; L Parapia; G Cox; S Johnson
Journal: Cancer Chemother Pharmacol Date: 1988 Impact factor: 3.333

Review 3. Idarubicin (4-demethoxydaunorubicin). A preliminary overview of preclinical and clinical studies.

Authors: F Ganzina; M A Pacciarini; N Di Pietro
Journal: Invest New Drugs Date: 1986 Impact factor: 3.850

4. Oral idarubicin in non-Hodgkin's lymphomas.

Authors: M Lopez; L Di Lauro; P Papaldo
Journal: Invest New Drugs Date: 1986 Impact factor: 3.850

5. Phase II trial with oral idarubicin in advanced breast cancer.

Authors: M Lopez; L Di Lauro; P Papaldo; B Lazzaro; F Ganzina; N Di Pietro
Journal: Invest New Drugs Date: 1986 Impact factor: 3.850

6. Significant dose Escalation of Idarubicin in the treatment of aggressive Non- Hodgkin Lymphoma leads to increased hematotoxicity without improvement in efficacy in comparison to standard CHOEP-14: 9-year follow up results of the CIVEP trial of the DSHNHL.

Authors: Karin Hohloch; Carsten Zwick; Marita Ziepert; Dirk Hasenclever; Ulrich Kaiser; Andreas Engert; Heinz-Gert Höffkes; Frank Kroschinsky; Rolf Mesters; Andreas C Feller; Markus Löffler; Lorenz Trümper; Michael Pfreundschuh
Journal: Springerplus Date: 2014-01-03

6 in total